论文信息 - Lenalidomide for second-line treatment of advanced hepatocellular cancer (HCC): A Brown University Oncology Group phase II study. - 字舞流文

Lenalidomide for second-line treatment of advanced hepatocellular cancer (HCC): A Brown University Oncology Group phase II study.

J. Wands | K. Faricy-Anderson | K. Perez | K. Charpentier | A. Kaubisch | A. Taber | T. Miner | Kalyan C Mantripragada | H. Safran | D. Martel | D. Berz | G. Dubel | K. Rosati | D. Luppe | P. Wingate | Y. Eng | J. Victor | P. Bakalarski | D. Isdale | Joseph Espat